Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2513 to 2562 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon 1 (neuroendocrine-specific protein). [source:swissprot;acc:q16799]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6204.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6360.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02521\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eh-domain containing protein 1 (testilin) (hpast1). [source:swissprot;acc:q9h4m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6203.92\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6360.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0252\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eh-domain containing protein 3. [source:swissprot;acc:q9nzn3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6203.94\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eh-domain containing protein 4 (eh domain-containing protein fksg7) (hepatocellular carcinoma-associated protein 10/11). [source:swissprot;acc:q9h223]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6203.95\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6360.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02519\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eh-domain containing protein 2. [source:swissprot;acc:q9nzn4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6203.96\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sin3 associated polypeptide p18 (2hor0202). [source:swissprot;acc:o00422]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6204.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6360.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02516\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenine phosphoribosyltransferase (ec 2.4.2.7) (aprt). [source:swissprot;acc:p07741]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5964.17\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6113.96\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02511\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 1 (ec 1.1.1.62) (17-beta-hsd 1) (placental 17-beta-hydroxysteroid dehydrogenase) (20 alpha- hydroxysteroid dehydrogenase) (20-alpha-hsd) (e2dh). [source:swissprot;acc:p14061]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
17 beta-hydroxysteroid dehydrogenase. [source:sptrembl;acc:q13034]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinol dehydrogenase 8 (all-trans); photoreceptor outer segment all-trans retinol dehydrogenase. [source:refseq;acc:nm\_015725]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase i 40 kda polypeptide (ec 2.7.7.6) (rpa40) (rpa39). [source:swissprot;acc:o15160]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3803.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3710.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02508\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myo-inositol 1-phosphate synthase a1. [source:refseq;acc:nm\_016368]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
8695.15\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8912.98\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02505\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2525\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arsenical pump-driving atpase (ec 3.6.3.16) (arsenite-translocating atpase) (arsenical resistance atpase) (arsenite-transporting atpase) (arsa) (asna-i). [source:swissprot;acc:o43681]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2526\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein gdx (ubiquitin-like protein 4). [source:swissprot;acc:p11441]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
large proline-rich protein bat3 (hla-b-associated transcript 3) (g3). [source:swissprot;acc:p46379]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon 4 (neurite outgrowth inhibitor) (nogo protein) (foocen) (neuroendocrine-specific protein) (nsp) (neuroendocrine specific protein c homolog) (rtn-x) (reticulon 5) (my043 protein). [source:swissprot;acc:q9nqc3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6205.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6359.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02487\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-147. [source:swissprot;acc:q9y3e5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6436.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6283\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02442\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s9, mitochondrial precursor (mrp-s9). [source:swissprot;acc:p82933]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3880.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3788.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02431\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymyositis/scleroderma autoantigen 2 (autoantigen pm/scl 2) (polymyositis/scleroderma autoantigen 100 kda) (pm/scl-100) (p100 polymyositis-scleroderma overlap syndrome associated autoantigen). [source:swissprot;acc:q01780]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6141.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6291.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l15. [source:swissprot;acc:p39030]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4888.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5006.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02401\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase i 135 kda polypeptide (ec 2.7.7.6) (rna polymerase i subunit 2) (rpa135). [source:swissprot;acc:q9h9y6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3847.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3759.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02356\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thyroid receptor interacting protein 12 (trip12). [source:swissprot;acc:q14669]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6452.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6603.94\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0235\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.61) (e2) (e2k). [source:swissprot;acc:p36957]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 1. [source:swissprot;acc:q13596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5932.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6071.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02348\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6669.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6824.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02327\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 4 (ec 1.1.1.62) (17-beta-hsd 4) (17-beta-hydroxysteroid dehydrogenase 4). [source:swissprot;acc:p51659]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7121.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7286.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinol-cytochrome c reductase iron-sulfur subunit, mitochondrial precursor (ec 1.10.2.2) (rieske iron-sulfur protein) (risp). [source:swissprot;acc:p47985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3805.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3718.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, somatic form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type i). [source:swissprot;acc:p08559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6672.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6827.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0232\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tata box binding protein-associated factor, rna polymerase ii, q; taf7-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 50 kd; tbp-associated factor, rna polymerase ii, q. [source:refseq;acc:nm\_024885]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8542.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8740.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02319\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
osteoclast stimulating factor 1. [source:swissprot;acc:q92882]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4708.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4817.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 55 kda subunit (tafii-55) (tafii55). [source:swissprot;acc:q15545]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8565.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8760.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02277\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxiredoxin 5, mitochondrial precursor (prx-v) (peroxisomal antioxidant enzyme) (plp) (thioredoxin peroxidase pmp20) (antioxidant enzyme b166) (aoeb166) (tpx type vi) (liver tissue 2d-page spot 71b) (alu co-repressor 1) (sbbi10). [source:swissprot;acc:p30044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6239.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6378.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02222\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 3 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 3). [source:swissprot;acc:p47986]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8285.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8107.49\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02197\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 14.5 kda polypeptide (ec 2.7.7.6) (rpb9) (rpb14.5). [source:swissprot;acc:p36954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4763.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4868.66\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-phosphoinositide dependent protein kinase-1 (ec 2.7.1.37) (hpdk1). [source:swissprot;acc:o15530]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3370.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3444.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37 (g1.16). [source:swissprot;acc:p02403]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4725.79\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4824.4\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 1 (pre-mrna splicing factor sf2, p33 subunit) (alternative splicing factor asf-1). [source:swissprot;acc:q07955]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
amidophosphoribosyltransferase precursor (ec 2.4.2.14) (glutamine phosphoribosylpyrophosphate amidotransferase) (atase) (gpat). [source:swissprot;acc:q06203]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 17. [source:swissprot;acc:q15036]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonuclease p protein subunit p30 (ec 3.1.26.5) (rnasep protein p30) (rnase p subunit 2). [source:swissprot;acc:p78346]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4884.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4985.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02077\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related protein rab-37. [source:swissprot;acc:q96ax2]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3852.99\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3775.86\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02043\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related protein rab-26. [source:swissprot;acc:q9ulw5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 33 kda polypeptide (ec 2.7.7.6) (rpb3) (rna polymerase ii subunit 3) (rpb33) (rpb31). [source:swissprot;acc:p19387]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shwachman-bodian-diamond syndrome protein (cgi-97). [source:swissprot;acc:q9y3a5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4883.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0203\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin-like protein rip (hiv-1 rev-binding protein) (rev interacting protein) (rev/rex activation domain-binding protein). [source:swissprot;acc:p52594]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5291.65\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5187.78\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02002\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 1 (sh3 domain-containing protein 1a) (sh3p17). [source:swissprot;acc:q15811]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pram-1 protein; pml-rara target gene encoding an adaptor molecule-1. [source:refseq;acc:nm\_032152]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 2 (sh3 domain-containing protein 1b) (sh3p18) (sh3p18-like wasp associated protein). [source:swissprot;acc:q9nzm3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hiv-1 rev binding protein-like; rev/rex activation domain binding protein-related. [source:refseq;acc:nm\_006076]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgthba protein (-14 gene protein). [source:swissprot;acc:q12980]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/